The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Designing organometallic compounds for catalysis and therapy
Abstract
Bioorganometallic chemistry is a rapidly developing area of research. In recent years organometallic compounds have provided a rich platform for the design of effective catalysts, e.g. for olefin metathesis and transfer hydrogenation. Electronic and steric effects are used to control both the thermodynamics and kinetics of ligand substitution and redox reactions of metal ions, especially Ru(II). Can similar features be incorporated into the design of targeted organometallic drugs? Such complexes offer potential for novel mechanisms of drug action through incorporation of outer-sphere recognition of targets and controlled activation features based on ligand substitution as well as metal- and ligand-based redox processes. We focus here on η(6)-arene, η(5)-cyclopentadienyl sandwich and half-sandwich complexes of Fe(II), Ru(II), Os(II) and Ir(III) with promising activity towards cancer, malaria, and other conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Development of L2X2RuCHR Olefin Metathesis Catalysts: An Organometallic Success Story
Trnka, T. M., & Grubbs, R. H. (2001) · Accounts of Chemical Research · doi:10.1021/ar000114f · Cited by 3,561
Industrial biocatalysis today and tomorrow
Schmid, A., Dordick, J. S., Hauer, B., Kiener, A., Wubbolts, M., & Witholt, B. (2001) · Nature · doi:10.1038/35051736 · Cited by 2,405
Asymmetric Transfer Hydrogenation Catalyzed by Chiral Ruthenium Complexes
Noyori, R., & Hashiguchi, S. (1997) · Accounts of Chemical Research · doi:10.1021/ar9502341 · Cited by 2,338
Ruthenium-Based Heterocyclic Carbene-Coordinated Olefin Metathesis Catalysts
Vougioukalakis, G. C., & Grubbs, R. H. (2010) · Chemical Reviews · doi:10.1021/cr9002424 · Cited by 2,018
The therapeutic potential of carbon monoxide
Motterlini, R., & Otterbein, L. E. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3228 · Cited by 1,638
Grubbs, R. H. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.05.124 · Cited by 1,205
Mechanism and Activity of Ruthenium Olefin Metathesis Catalysts
Sanford, M. S., Love, J. A., & Grubbs, R. H. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010624k · Cited by 1,144
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Catalysis by Palladium Pincer Complexes
Selander, N., & Szabo, K. J. (2010) · Chemical Reviews · doi:10.1021/cr1002112 · Cited by 847
In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes
Scolaro, C., Bergamo, A., Brescacín, L., Delfino, R., Cocchietto, M., Laurenczy, G., Geldbach, T. J., Sava, G., & Dyson, P. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050015d · Cited by 784
Cited by
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
Self-citationOrganoiridium Complexes: Anticancer Agents and Catalysts
Liu, Z., & Sadler, P. J. (2014) · Accounts of Chemical Research · doi:10.1021/ar400266c · Cited by 573
Self-citationN-Heterocyclic carbene metal complexes in medicinal chemistry
Oehninger, L., Rubbiani, R., & Ott, I. (2013) · Dalton Trans. · doi:10.1039/c2dt32617e · Cited by 560
Lazarević, T., Rilak, A., & Bugarčić, Ž. D. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.007 · Cited by 428
Meier-Menches, S. M., Gerner, C., Berger, W., Hartinger, C. G., & Keppler, B. K. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00332c · Cited by 425
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Self-citationThe path for metal complexes to a DNA target
Komor, A. C., & Barton, J. K. (2013) · Chemical Communications · doi:10.1039/c3cc00177f · Cited by 384
Methods for the regeneration of nicotinamide coenzymes
Wu, H., Tian, C., Song, X., Liu, C., Yang, D., & Jiang, Z. (2013) · Green Chemistry · doi:10.1039/c3gc37129h · Cited by 382
Advances in the design of organometallic anticancer complexes
Zhang, P., & Sadler, P. J. (2017) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2017.03.038 · Cited by 369
Self-citationAnticancer cyclometalated complexes of platinum group metals and gold
Cutillas, N., Yellol, G. S., de Haro, C., Vicente, C., Rodríguez, V., & Ruiz, J. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.03.024 · Cited by 332
Bioactive iridium and rhodium complexes as therapeutic agents
Leung, C.-H., Zhong, H.-J., Chan, D. S.-H., & Ma, D.-L. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.01.034 · Cited by 303
The elements of life and medicines
Chellan, P., & Sadler, P. J. (2015) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2014.0182 · Cited by 274
Self-citationTransfer hydrogenation catalysis in cells as a new approach to anticancer drug design
Soldevila-Barreda, J. J., Romero-Canelón, I., Habtemariam, A., & Sadler, P. J. (2015) · Nature Communications · doi:10.1038/ncomms7582 · Cited by 262
Self-citationZhong, H.-J., Lu, L., Leung, K.-H., Wong, C. C. L., Peng, C., Yan, S.-C., Ma, D.-L., Cai, Z., David Wang, H.-M., & Leung, C.-H. (2015) · Chemical Science · doi:10.1039/c5sc02321a · Cited by 138
Metadata
- Authors
- Noffke, A. L., Habtemariam, A., Pizarro, A. M., & Sadler, P. J.
- Venue
- Chemical Communications
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2012
- Volume
- 48
- Issue
- 43
- Pages
- 5219
- ISSN
- 1359-7345 (ISSN-L)
- 1364-548X
- OpenAlex
- W2093968893
- Cited by
- 370
- References
- 90
- FWCI
- 19.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.